Amprion Announces SYNTap™ Biomarker Test For Early Detection Of Parkinson's Disease (PD), Lewy Body Dementia (LBD), And Alzheimer's Disease (AD)
Amprion has announced the commercial rollout of its innovative SYNTap Biomarker Test, a first-in-class laboratory-developed test (LDT) for accurate...
Source: photonicsonline.com